© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Kutikov points out that not every mass needs to be resected and that patients need to understand the risks associated with each decision they make in the treatment process.
Alexander Kutikov, MD, FACS, associate professor of Urologic Oncology, Fox Chase Cancer Center, discusses the options patients with a renal tumor have. Kutikov points out that not every mass needs to be resected and that patients need to understand the risks associated with each decision they make in the treatment process.